| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/20/1995 | WO1995010777A1 Detection and treatment of breast and gynecological cancer |
| 04/20/1995 | WO1995010630A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | WO1995010591A1 Protease-containing cleaning compositions |
| 04/20/1995 | WO1995010539A1 Growth differentiation factor-10 |
| 04/20/1995 | WO1995010525A1 Stable solvates of avermectin compounds |
| 04/20/1995 | WO1995010521A1 Therapeutic agents |
| 04/20/1995 | WO1995010520A1 3-pyrrolidinylthio-carbapenem derivatives and their antimicrobal activity |
| 04/20/1995 | WO1995010519A1 Quinolizinone type compounds |
| 04/20/1995 | WO1995010518A1 ALKOXY ALKYL CARBAMATES FROM IMIDAZO (1,2-a)PYRIDINES |
| 04/20/1995 | WO1995010517A1 Indole derivatives as nmda antagonists |
| 04/20/1995 | WO1995010516A1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 04/20/1995 | WO1995010515A1 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 04/20/1995 | WO1995010514A1 Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 04/20/1995 | WO1995010513A1 Benzothiophenes and related compounds as estrogen agonists |
| 04/20/1995 | WO1995010506A1 1n-alkyl-n-arylpyrimidinamines and derivatives thereof |
| 04/20/1995 | WO1995010307A1 Radiation sensitization using texaphyrins |
| 04/20/1995 | WO1995010306A1 Prophylaxis in the parenteral administration of particulate dispersions |
| 04/20/1995 | WO1995010305A1 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes |
| 04/20/1995 | WO1995010294A1 Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract |
| 04/20/1995 | WO1995010289A1 Use of lithium compounds for treating high blood pressure |
| 04/20/1995 | WO1995010288A1 Hepatitis b virus interacts with cellular dna repair processes |
| 04/20/1995 | WO1995010286A1 Inhibitors of phosphoinositide-specific phospholipase c |
| 04/20/1995 | WO1995010285A1 The use of inositoltrisphosphate for the preparing of medicaments |
| 04/20/1995 | WO1995010284A1 Method of treating androgenic alopecia with 5-alpha reductase inhibitors |
| 04/20/1995 | WO1995010283A1 Treatment of medical disorders associated with free radical formation |
| 04/20/1995 | WO1995010282A1 Use of phosphatase inhibitors for the manufacture of a medicament in the treatment of channel related diseases |
| 04/20/1995 | WO1995010281A1 Combination therapy for hiv infection |
| 04/20/1995 | WO1995010280A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 04/20/1995 | WO1995010279A1 Treatment of allergic disorders with terfenadine |
| 04/20/1995 | WO1995010278A1 Treatment of allergic disorders with terfenadine carboxylate |
| 04/20/1995 | WO1995010277A1 Analgesic agent and its use |
| 04/20/1995 | WO1995010276A1 Levobupivacaine useful for managing chronic pain |
| 04/20/1995 | WO1995010275A1 Use of alpha receptor antagonists for the treatment of chronic muscle pain |
| 04/20/1995 | WO1995010274A1 Aqueous pharmaceutical composition |
| 04/20/1995 | WO1995010273A1 Use of protein kinase c activators for the manufacture of a medicament for killing hypoxic tumor cells |
| 04/20/1995 | WO1995010272A1 Hydroxyl ions as unique therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents and processes for preparing them |
| 04/20/1995 | WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/1995 | WO1995010270A1 Method for treating urinary incontinence using optically pure s-terodiline |
| 04/20/1995 | WO1995010269A1 Treatment of urinary incontinence and other disorders with r-terodiline and hydroxylated derivatives thereof |
| 04/20/1995 | WO1995010268A1 Prevention of hiv infection |
| 04/20/1995 | WO1995010267A1 Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers |
| 04/20/1995 | WO1995010265A1 Therapeutic delivery compositions and methods of use thereof |
| 04/20/1995 | WO1995010258A1 Inhibition of urinary calculi growth |
| 04/20/1995 | WO1995010199A1 A drink containing mucilaginous polysaccharides and its preparation |
| 04/20/1995 | WO1995010185A1 Superoxide dismutase and mimetics thereof |
| 04/20/1995 | DE4403311C1 Process for the preparation of nevirapine (11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-d iazepin]-6-one) |
| 04/20/1995 | DE4335523A1 Antiallergic composition |
| 04/20/1995 | DE4335454A1 Geriatric medical composition |
| 04/20/1995 | CA2614621A1 Superoxide dismutase and mimetics thereof |
| 04/20/1995 | CA2178341A1 Detection and treatment of breast and gynecological cancer |
| 04/20/1995 | CA2174136A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | CA2174082A1 Use of phosphatase inhibitors for the manufacture of a medicament in the treatment of channel related diseases |
| 04/20/1995 | CA2174080A1 1n-alkyl-n-arylpyrimidinamines and derivatives thereof |
| 04/20/1995 | CA2173964A1 Prevention of hiv infection |
| 04/20/1995 | CA2173857A1 Therapeutic agents |
| 04/20/1995 | CA2173738A1 Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers |
| 04/20/1995 | CA2173627A1 Hydroxyl ions as unique therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents and processes forpreparing them |
| 04/20/1995 | CA2173459A1 Quinolizinone type compounds |
| 04/20/1995 | CA2173456A1 Inhibitors of phosphoinositide-specific phospholipase c |
| 04/20/1995 | CA2173243A1 Benzothiophenes and related compounds as estrogen agonists |
| 04/20/1995 | CA2172960A1 Treatment of allergic disorders with terfenadine carboxylate |
| 04/20/1995 | CA2171546A1 Growth differentiation factor-10 |
| 04/20/1995 | CA2171449A1 Indole derivatives as nmda antagonists |
| 04/20/1995 | CA2170591A1 Treatment of medical disorders associated with free radical formation |
| 04/20/1995 | CA2118361A1 Novel mannosidase inhibitors, process for their preparation and their use as therapeutic agents |
| 04/20/1995 | CA2112871A1 Preparation process of imidazole sulfur derivatives and new intermediate products obtained |
| 04/19/1995 | EP0648836A1 MHC class II transactivator (CIITA) and uses thereof |
| 04/19/1995 | EP0648780A1 Heterocyclic thrombin inhibitors |
| 04/19/1995 | EP0648779A2 New 11-benzaldehyde oxime, 17-beta methoxy, 17 alpha methoxymethyl derivates of estradiene, a process for their preparation and pharmaceutical compositions containing them |
| 04/19/1995 | EP0648778A2 11-Benzaldoximeestradiene-derivates, a process for their preparation and pharmaceutical compositions containing them |
| 04/19/1995 | EP0648771A1 Galanthamine derivatives, a process for their preparation and their use as medicaments |
| 04/19/1995 | EP0648769A1 12-Hetero-substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizium salts and compositions and method of use thereof |
| 04/19/1995 | EP0648767A1 Piperdine and piperazine derivatives which affect the C.N.S. |
| 04/19/1995 | EP0648766A1 Agent acting on the central nervous system, method for its preparation and pharmaceutical compositions containing such agent |
| 04/19/1995 | EP0648763A1 Process for the preparation of sulfur derivatives of imidazole and intermediates obtained |
| 04/19/1995 | EP0648762A2 Bicyclic compounds as excitatory amino acid receptor antagonists |
| 04/19/1995 | EP0648760A2 Triazine derivative, production and use thereof |
| 04/19/1995 | EP0648759A1 Antihistaminic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/19/1995 | EP0648758A1 4-Arylamino-benzopyran and related compounds |
| 04/19/1995 | EP0648745A1 Arylalkylamine having anticonvulsant and neuroprotective properties |
| 04/19/1995 | EP0648744A1 Phenylalkanolamine derivatives as antagonists of the NMDA receptor |
| 04/19/1995 | EP0648741A1 1,2,3,4-Tetrahydronaphthalene, chroman and thiochroman derivatives as antithrombotic agents |
| 04/19/1995 | EP0648503A1 Pro-prodrugs, their production and use |
| 04/19/1995 | EP0648496A1 Therapeutic compositions for use in the treatment of skin lesions and method of making same |
| 04/19/1995 | EP0648495A2 Cation-complexed polysaccharides |
| 04/19/1995 | EP0648494A1 Rapamycin formulations for oral administration |
| 04/19/1995 | EP0648493A1 A method to reverse the phenotype of transformed cells by the transcription factor IRF-1 |
| 04/19/1995 | EP0648492A2 Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof |
| 04/19/1995 | EP0648491A2 Eosinophil chemotaxis inhibitor |
| 04/19/1995 | EP0648490A2 Septicemia suppressing substitution fluid preparation |
| 04/19/1995 | EP0648489A1 Arylalkylamides having neuroprotective properties |
| 04/19/1995 | EP0648488A1 Method to alter hairgrowth and compositions therefor |
| 04/19/1995 | EP0648486A1 Stable liquid preparation of a vitamin complex for internal use |
| 04/19/1995 | EP0648279A1 Acceptor for fucosyltransferase |
| 04/19/1995 | EP0648271A1 Adenovirus mediated transfer of genes to the gastrointestinal tract |
| 04/19/1995 | EP0648269A1 Novel polypeptides having nmda receptor activity, nucleic acids encoding said polypeptides and applications |
| 04/19/1995 | EP0648261A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
| 04/19/1995 | EP0648254A1 Luminescent article with high phosphor to binder ratio and manufacture thereof. |
| 04/19/1995 | EP0648223A1 Substituted lactose derivatives as cell adhesion inhibitors |
| 04/19/1995 | EP0648218A1 Therapeutic nucleosides |